The Role of SAMe in the Treatment of Liver Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Thompson M, Bauer B, Loehrer L, Cha S, Mandrekar J, Sood A J Altern Complement Med. 2009; 15(5):523-9.
PMID: 19422296 PMC: 2875864. DOI: 10.1089/acm.2008.0402.
S-adenosylmethionine (SAMe) in a feline acetaminophen model of oxidative injury.
Webb C, Twedt D, Fettman M, Mason G J Feline Med Surg. 2003; 5(2):69-75.
PMID: 12670431 PMC: 10822223. DOI: 10.1016/S1098-612X(02)00017-7.
References
1.
Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno M
. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol. 1989; 24(4):407-15.
DOI: 10.3109/00365528909093067.
View
2.
Feo F, Pascale R, Garcea R, Daino L, Pirisi L, Frassetto S
. Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats. Toxicol Appl Pharmacol. 1986; 83(2):331-41.
DOI: 10.1016/0041-008x(86)90310-8.
View
3.
Vore M
. Estrogen cholestasis. Membranes, metabolites, or receptors?. Gastroenterology. 1987; 93(3):643-9.
View